Skip to main content
Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited

ISIN: INE385W07059
key_star

Key Highlights

key_star
yield_img

Yield

rating_img

Rating

min_invest_img

Min. Invest

10.5%

A

~₹ 91.57K

Interest

Principal

Maturity date

Seniority

Quarterly

Partial Redemption By Face Value

20/01/2029

Senior

About the Company

Dishman Carbogen Amcis Limited is a global pharmaceutical company that provides contract research, development, and manufacturing services for drug substances and specialty chemicals, supporting pharmaceutical and biotech clients from early-stage research to commercial production, with headquarters in Ahmedabad, India and operations across India, Europe, and Asia.

Key Management Personnel

Janmejay R. Vyas

Founder & Chairman

Financials

Yearly

*All values are in cr

Company Updates

Dishman Carbogen Amcis Ltd Hits Intraday High with 7.31% Surge on 3 Feb 2026

11 weeks ago

Dishman Carbogen Amcis Ltd recorded a robust intraday performance on 3 Feb 2026, surging 7.31% to touch a day’s high of Rs 233.5, significantly outperforming the broader market and its sector peers.

Samunnati raises Rs 2,300 Cr in FY25; expands lender base

54 weeks ago

Looking ahead, Samunnati has a debt pipeline exceeding Rs 600 crore for the first quarter of FY26, indicating continued momentum in its financing activity.

Other disclosures

Dishman Carbogen Amcis Limited
Yield 10.5%

Units

Inv. Amount

Exp. Returns

Payout Schedule

Loading bank accounts...

By proceeding I agree to the T&C and Privacy Policy